Fingerprint
Dive into the research topics of 'Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial
Tomasz J. Guzik, Chinthanie Ramasundarahettige, Nana Pogosova, Patricio Lopez-Jaramillo, Leanne Dyal, Scott D. Berkowitz, Eva Muehlhofer, Deepak L. Bhatt, Keith A.A. Fox, Salim Yusuf, John W. Eikelboom
Research output: Articles / Notes › Scientific Article › peer-review